Our Own Special IssuesTo search this page, press "Ctrl-f".
References 1989Alyautdin R, Filippov V, and Nemirovskii A. Properties of magnet-controlled liposomes containing curare-like drugs. Farmatsiya (Moscow), 38: 20-23 (1989).
Bassett CA. Fundamental and practical aspects of therapeutic uses of pulsed electromagnetic fields (PEMFs). CRC Crit. Rev. Biomed. Eng. 17: 451-529 (1989).
Chang M and Colvin MS. Magnetic particles. US Patent No. 4873102, 1989.
Gallo JM, Hung CT, Gupta PK, and Perrier DG. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat. J. Pharmacokin. Biopharm. 17: 305-326 (1989).
Gupta PK and Hung CT. Magnetically controlled targeted micro-carrier systems. Life Sci. 44: 175-186 (1989).
Howard MA, Grady MS, Ritter RC, Gillies GT, Quate EG, and Molloy JA. Magnetic movement of a brain thermoceptor. Neurosurgery, 24: 444-448 (1989).
Kharkevich DA, Alyautdin RN, and Filippov VI. Employment of magnet-susceptible microparticles for the targeting of drugs. J. Pharm. Pharmacol. 41: 286-288 (1989).
Van Hecke P, Marchal G, Decrop E, and Baert AL. Experimental study of the pharmacokinetics and dose response of ferrite particles used as contrast agent in MRI of the normal liver of the rabbit. Invest. Radiol. 24: 397-399 (1989).
Vyas SP and Malaiya A. In vivo characterization of indomethacin magnetic polymethyl methacrylate nanoparticles. J. Microencapsulation, 6: 493-499 (1989).
Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, and Lewis J. Superparamagnetic Iron Oxide: Pharmacokinetics and toxicity. AJR, 152: 167-173 (1989).
Gallo JM and Hassan EE. Receptor-mediated magnetic carriers: Basis for targeting. Pharmaceut. Res. 5: 300-304 (1988).
Gomiyo H and Kaneki H. Liposomes containing magnetite. Patent, 63-14717: (1988).
Ranney DF. Magnetically controlled devices and biomodulation. In Tyle P (Ed.). Drug delivery devices. Marcel Dekker, New York, NY, 1988, pp. 325-368.
Saslawski O, Weingarten C, Benoit JP, and Couvreur P. Magnetically responsive microspheres for the pulsed delivery of insulin. Life Sci. 42: 1521-1528 (1988).
Torchilin VP, Papisov MI, Orekhova NM, Belyaev AA, Petrov AD, and Ragimov SE. Magnetically driven thrombolytic preparation containing immobilized streptokinase-targeted transport and action. Haemostasis, 18: 113-116 (1988).
Yoshimoto T, Ohwada K, Takahashi K, Matsushima A, Saito Y, and Inada Y. Magnetic urokinase: Targeting of urokinase to fibrin clot. Biochem. Biophys. Res. Commun. 152: 739-743 (1988).
Papisov MI, Savelyev VY, Sergienko VB, and Torchilin VP. Magnetic drug targeting. In vivo kinetics of radiolabeled magnetic drug carriers. Int. J. Pharm. 40: 201-206 (1987).
Papisov MI and Torchilin VP. Magnetic drug targeting. Targeted drug transport by magnetic microparticles: factors influencing therapeutic effect. Int. J. Pharm. 40: 207-214 (1987).
Ranney DF and Huffaker HH. Magnetic microspheres for the targeted controlled release of drugs and diagnostic agents. Ann. NY Acad. Sci. 507: 104-119 (1987).
Widder DJ, Greif WL, Widder KJ, Edelman RR, and Brady TJ. Magnetite albumin microspheres: A new MR contrast material. AJR, 148: 399-404 (1987).
Frankel RB and Blakemore RP. Magnetite and magnetotaxis in microorganisms. Advances in Experimental Medicine and Biology, 238: 321-330 (1986).
Kemshead JT, Heath L, Gibson FM, Katz F, Richmond F, Treleaven J, and Ugelstad J. Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: Experiences, improvements and observations. Br. J. Cancer, 54: 771-778 (1986).
Kiwada H, Sato J, Yamada S, and Kato Y. Feasibility of magnetic liposomes as a targeting device for drugs. Chem. Pharm. Bull. 34: 4253-4258 (1986).
Lee KC, Koh IB, and Oh IJ. Preparation of magnetic gelatin microspheres for the targeting of drugs. Arch. Pharm. Res. 9: 145-152 (1986).
Liburdy RP, Tenforde TS, and Magin RL. Magnetic field-induced drug permeability in liposome vesicles. Radiat. Res. 108: 102-111 (1986).
Mann S, Hannington JP, and Williams RJP. Phospholipid vesicles as a model system for biomineralization. Nature, 324: 565-567 (1986).
Maret G, Kiepenheuer J, and Boccara N. Biophysical effects of steady magnetic fields. Springer Verlag, Berlin, 1986.
Sako M and Hirota S. Embolotherapy of hepatomas using ferromagnetic microspheres, its clinical evaluation and the prospect of its use as a vehicle in chemoembolo-hyperthermic therapy. Gan To Kagaku Ryoho, 13: 1618-1624 (1986).
Sternheim MM and Kane JW. Magnetism. In Sternheim MM and Kane JW (Eds.). General Physics. John Wiley + Sons, New York, 1986, pp. 402-426.
Dubrul W. Cobalt magnet guides surgeons's needle to tissue expander. Design News, 41: 94-95 (1985).
Gallo JM. Pharmacokinetic studies of adriamycin delivered via magnetic albumin microspheres and of ibuprofen in synovial fluid. Ph.D. thesis, University of Arizona, Tucson, AZ, U.S.A. 1985.
Giebel W, Wagner H, and Scheibe F. Preliminary electrophysiological data after the obliteration of cochlear blood vessels by the action of a magnetic field on circulating iron particles. Arch. Otorhinolaryngol. 242: 337-341 (1985).
Kandzia J, Haas W, Leyhausen G, and Müller-Ruchholtz W. Cell separation: Comparison between magnetic immuno-microspheres (MIMS) and FACS. In Schütt W and Klinkmann H (Eds.). Cell Electrophoresis. Walter de Gruyter, Berlin, 1985, pp. 87-93.
Petersson L and Ehrenberg A. Highly sensitive Faraday balance for magnetic susceptibility studies of dilute protein solutions. Rev. Sci. Instrum. 56: 575-580 (1985).
Rusetskii AN, Panisov MI, Ruuge EK, and Torchilin VP. Substantiation of using magnet-directed localization of drugs for the treatment of thrombosis. Biulleten Vsesoiuznogo Kardiologicheskogo Nauchnogo Tsentra Amn Sssr, 8: 100-105 (1985).
Sako M, Hirota S, and Ohtsuki S. Clinical evaluation of ferromagnetic microembolization for the treatment of hepatocellular carcinoma. Ann. Radiol. 29: 200-204 (1985).